Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Stocks Yahoo Finance By Yahoo Finance 25 Jun 2026 12:40 1 min read

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.